title: L-tryptophan attenuation of the dopaminergic and behavioral responses to cocaine.
abstract: This study assessed the effects of acute intravenous L-tryptophan (neutral amino acid precursor for serotonin) administration on cocaine-induced dopaminergic responses. Male Sprague-Dawley rats were surgically implanted with guide cannulas in the nucleus accumbens 5 days prior to the study and with vascular catheters (carotid artery and jugular vein) on the day prior to the study. Using microdialysis, extracellular nucleus accumbens dopamine levels were measured in freely moving rats. Following a 2 h equilibration period, animals were randomized (n=7-8 per group) to receive either a constant intravenous (IV) infusion of L-tryptophan (200 mg/kg/h) or an equal volume (2 ml/h) of saline. Ninety minutes into the infusion, cocaine (20 mg/kg) was injected intra-peritoneally. Cocaine increased nucleus accumbens microdialysate dopamine levels (500% at 30 min). This was associated with marked hyperactivity. Tryptophan infusion elevated plasma tryptophan (8-fold), and blunted the cocaine-induced increase in nucleus accumbens microdialysate dopamine levels by approximately 60%. Furthermore, tryptophan attenuated the cocaine-induced locomotor activity. These neurochemical and behavioral effects of tryptophan were associated with a marked increase in brain tissue serotonin content. The results of these studies demonstrate the feasibility of acute dietary manipulation of neurochemical and behavioral responses to cocaine. The duration, adaptation and tolerance to these effects remain to be elucidated.
authors.affiliation: Department of Physiology, LSUMC, New Orleans, LA 70112, USA. pmolin@lsuhsc.edu
authors.forename: P E
authors.initials: PE
authors.lastname: Molina
authors.forename: N
authors.initials: N
authors.lastname: Ahmed
authors.forename: J
authors.initials: J
authors.lastname: Gatley
authors.forename: N D
authors.initials: ND
authors.lastname: Volkow
authors.forename: N N
authors.initials: NN
authors.lastname: Abumrad
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D003042:Cocaine / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D004298:Dopamine / Q000378:metabolism*; D006948:Hyperkinesis / Q000139:chemically induced / Q000517:prevention & control; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008297:Male; D017551:Microdialysis; D009292:Narcotic Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D009714:Nucleus Accumbens / Q000187:drug effects / Q000378:metabolism; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D014364:Tryptophan / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D009292:Narcotic Antagonists; D014364:Tryptophan; D003042:Cocaine; D004298:Dopamine